Hospital Medicine

Daily self-imaging scans and in-office OCT scans graded by human experts agreed on the fluid status in 96% of the cases.

Data show foveal thickness fluctuation was significantly associated with logMAR BCVA and the defect length of the foveal EZ band.

Both a higher self-reported water intake and a greater measured 24-h urine volume were tied to an increased DED prevalence.

All 6 screening strategies using wrist-worn wearable devices were estimated to be more effective than no screening.

Study data show 14% of eyes managed with intravitreal therapy in routine clinical care experienced ≥ 10 letter loss.

Patients with high preoperative sleep quality, high preoperative albumin level, free of digestive disease and undergoing total hip arthroplasty procedure are more likely to be discharged within 2 days as opposed to 3.

The worldwide burden of vision loss continues to climb, but there may be solutions with regards to better access to care and improved screening.

The latest EUA, for two-dose NVX-CoV2373, introduces a protein-based adjuvant vaccine to the COVID-19 prevention market.

Nearly half of the study cohort did not fill a statin prescription within 90 days after an ASCVD event.

Nonmetropolitan counties have a lower density of ophthalmologists compared to metropolitan counties.

Both the incidence and prevalence of the liver disease were higher in men than they were in women.

Washington DC, Hawaii, Oklahoma, California, Tennessee, West Virginia, Mississippi, Oregon, Washington, Louisiana, Kentucky, and New York all had HBV-related mortality rates higher than the national average.

The increase was highest for Hispanic and non-Hispanic Black Women.

Investigators presented the study at the Netherlands Ophthalmological Society Annual Congress, noting a potential cause for this trend could be the heightened cautiousness of surgical teams following the 2 month intermission due to the COVID-19 pandemic.

At 12 months, the mean VA change from baseline was 17.6 for BRVO patients and 18.6 for CRVO patients in the Netherlands.

New research from the UK suggests educational tools for caregivers are in use and beneficial, but none are universally applied.

In the Archway trial, 93.2% of patients preferred treatment with ranibizumab delivered via the PDS compared to only 1.3% of patients who preferred intravitreal injections.

New data suggest race and ethnicity, income, education, rural vs urban residence, and living in a food desert all were independently associated with poor diet quality.

The study popuation had a higher visual acuity at 12 months, despite receiving fewer aflibercept injections.

RBX2660, an investigational microbiota-based live biotherapeutic for the treatment of C difficile, safely and effectively reduced recurrent C diff for 6 months.

With limitations on fidaxomicin at their facility, a hospital looked at vancomycin usage to determine if they needed to align with the new IDSA/SHEA CDI treatment guideline.

Brent Forester, MD, MSc, discusses the confluence of biomarker and disease-targeting therapy in Alzheimer's, and the need to appropriately introduce these tools.

Christian Lillis of the Peggy Lillis Foundation for C. Diff Education & Advocacy discusses the need for greater industry-organization support and drug development.

Presence of chronic liver disease, prior use of gabapentin and being discharged to a long-term hospital or rehabilitation center are among some of the factors associated with a new opioid use disorder diagnosis.

A South Korea in-hospital assessment found that approximately half of all ordered CDI tests did not meet recommendation standards.

Isatuximab in combination with carfilzomib and dexamethasone (Kd) demonstrate the longest median progression free survival (mPFS) on a proteasome inhibitor backbone in multiple myeloma patients who relapsed after a prior therapy, including lenalidomide.

New data suggest prediction of SARS-CoV-2 and bacterial co-infection or superinfection could be provided for hospitalized patients.

A Massachusetts General Hospital investigator explains how the innovative DCD practice addresses both waitlist issues and transplant center's capabilities.

Investigators observed a potential risk between Black individuals with baseline signs of dehydration, SCT and related mortality over 30 years.

Investigators observed no reduction in readmission or mortality in a remote monitoring program with incentives for patients previously hospitalized for HF.